Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.796
+0.001 (0.16%)
Nov 21, 2024, 4:00 PM EST - Market closed
Vor Biopharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 29.14 | 31.72 | 28.87 | 21.49 | 11.75 | 4.22 | |
| Research & Development | 88.86 | 94.32 | 64.55 | 47.53 | 31.62 | 6.2 | |
| Operating Expenses | 118 | 126.04 | 93.42 | 69.02 | 43.37 | 10.42 | |
| Operating Income | -118 | -126.04 | -93.42 | -69.02 | -43.37 | -10.42 | |
| Interest Expense | - | - | - | - | - | -0.61 | |
| Interest & Investment Income | 5.54 | 8.17 | 1.32 | 0.12 | 0.03 | 0.15 | |
| Other Non Operating Income (Expenses) | - | - | - | - | - | 0.03 | |
| Pretax Income | -112.46 | -117.86 | -92.09 | -68.9 | -43.34 | -10.84 | |
| Net Income | -112.46 | -117.86 | -92.09 | -68.9 | -43.34 | -10.84 | |
| Preferred Dividends & Other Adjustments | - | - | - | 1.23 | 5.93 | 1.77 | |
| Net Income to Common | -112.46 | -117.86 | -92.09 | -70.13 | -49.26 | -12.61 | |
| Shares Outstanding (Basic) | 68 | 67 | 40 | 33 | 0 | 0 | |
| Shares Outstanding (Diluted) | 68 | 67 | 40 | 33 | 0 | 0 | |
| Shares Change (YoY) | 10.66% | 69.89% | 18.30% | 15548.00% | 85.85% | 30.96% | |
| EPS (Basic) | -1.65 | -1.75 | -2.33 | -2.10 | -230.56 | -109.71 | |
| EPS (Diluted) | -1.65 | -1.75 | -2.33 | -2.10 | -230.56 | -109.71 | |
| Free Cash Flow | -99.89 | -101.36 | -93.61 | -73.04 | -40.45 | -10.6 | |
| Free Cash Flow Per Share | -1.47 | -1.51 | -2.37 | -2.18 | -189.34 | -92.23 | |
| EBITDA | -114.44 | -122.54 | -90.89 | -67.58 | -42.76 | -10.33 | |
| D&A For EBITDA | 3.56 | 3.49 | 2.53 | 1.43 | 0.61 | 0.09 | |
| EBIT | -118 | -126.04 | -93.42 | -69.02 | -43.37 | -10.42 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.